Learning from nature's switches to develop new drug targets and biotech tools

Learning from nature's switches to develop new drug targets and biotech tools

🎙 Kevin Gardner 👥 2K 📅 May 11, 2026 ⏱ 43 min 👁 81 📄 expert opinion 🧭 2026-08-15
Available in: English (current) Français

Keywords

PAS domainLOV domainoptogeneticsHIF-2drug discovery

Summary

In this ASBMB Breakthrough webinar, Dr. Kevin Gardner presents his research on how cells sense and respond to environmental cues through protein domains, focusing on PAS and LOV domains. He begins by introducing the concept of conserved sensory domains that regulate diverse outputs, using examples from plants, humans, and marine organisms. The first part of the talk details the mechanism of LOV domains, which sense blue light via flavin chromophores, and how light-induced conformational changes control downstream effectors. Using NMR and X-ray crystallography, his lab revealed that light causes the unfolding of a C-terminal helix, acting as a switch to regulate protein activity. This principle is applied to engineer optogenetic tools, such as the light-activated transcription factor EL222, used in developmental biology. The second part shifts to hypoxia-inducible factors (HIFs), which are regulated by oxygen levels and are implicated in cancer. Gardner describes how his lab identified a water-filled cavity in the HIF-2α PAS-B domain that can be targeted by small molecules, leading to the development of potent inhibitors. This work culminated in the creation of Peloton Therapeutics and the clinical candidate belzutifan, now approved for treating certain cancers. The talk emphasizes the translational impact of fundamental structural biology research, from understanding basic mechanisms to developing novel therapeutics and biotech tools.

211 words

Critical Evaluation

Value of the Information & Strength of the Argument

The talk provides valuable insights into the structure-function relationships of PAS and LOV domains, illustrating how fundamental research can lead to practical applications. The argumentation is solid, grounded in experimental evidence from NMR, X-ray crystallography, and functional assays. The speaker clearly explains the logic behind each step, from initial observations to hypothesis testing and eventual translation. The presentation is well-structured, with clear transitions between the two main themes, and effectively demonstrates the power of interdisciplinary approaches in biochemistry.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is high, with the speaker referencing his own published work and that of others, including Nobel Prize-winning research on HIF. The sources are credible, and the speaker appropriately acknowledges contributions from collaborators and funding agencies. The title accurately reflects the content, which focuses on learning from natural switches to develop new drug targets and biotech tools. The talk is well-aligned with the title, covering both the mechanistic understanding and the translational applications.

168 words

Title / Content Match

The title accurately reflects the content, which focuses on how natural protein switches (PAS/LOV domains) can be understood and repurposed for drug development and biotechnological applications.

Quality & Reliability

8/10

The talk is delivered by a leading expert in structural biology, with a strong track record of publications in high-impact journals. The content is based on peer-reviewed research, including structural and functional studies, and is presented with appropriate scientific rigor. The speaker clearly distinguishes between established findings and hypotheses, and acknowledges the contributions of collaborators and funding agencies.

Key Moments

Cited Sources

  • ASBMB Breakthrough Webinar Series — The webinar series is organized by ASBMB, and this talk is part of it.
  • Journal of Biological Chemistry (JBC) — The webinar is brought to you by JBC, and the speaker is an editorial board member.

Concurring Sources

Contribution & Novelties

This talk provides a comprehensive overview of the speaker’s research on PAS and LOV domains, highlighting the translational potential of understanding protein switches. The novelty lies in the integration of structural biology, biochemistry, and drug discovery, demonstrating how fundamental insights into protein dynamics can lead to the development of novel therapeutics and biotechnological tools. The talk also emphasizes the importance of interdisciplinary collaboration and the value of basic research in driving innovation.

Pour aller plus loin :

  • PAS domain — Overview of PAS domains and their role in signal transduction.
  • LOV domain — Detailed information on LOV domains and their photochemistry.
  • Optogenetics — Techniques for controlling cellular activity with light, often using LOV domains.
  • Hypoxia-inducible factors — Transcription factors that respond to oxygen levels, central to the second part of the talk.
  • Belzutifan — The drug developed from this research, approved for treating certain cancers.

145 words

Radar Profile

The radar profile shows high scores in information quantity, quality, and technical level, with a slightly lower but still strong score in global reliability. This indicates a technically dense and reliable presentation, suitable for a scientific audience.

Reliability 8/10

💬 No comments were provided for analysis.